Abstract
One of the cancer treatment modalities is drug combinations. Nonetheless, the combined effect can be equal to, less than, or greater than each drug alone, and an effect greater than either agent alone does not necessarily imply synergism. This study, therefore, evaluated the cytotoxic interaction of temozolomide and doxycycline co-treatment in the human glioblastoma U87 cell line.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
